Works matching IS 10171606 AND DT 2022 AND VI 129
1
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 177
- Article
2
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 175
- Article
3
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 173
- Article
4
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 151
- Article
5
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 91
- Article
6
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 43
- Article
7
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 39
- Article
8
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 7
- Article
9
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 3
- Article
10
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2022, v. 129, p. 1
- Article